Upadacitinib 45mg modified-release tablets

SNOMED code
41089711000001107
Active compound
Upadacitinib
Preferred name basis
rINN - Recommended International Non-proprietary
Prescribable
✅ Yes
Dose form
Discrete
Dose size and units
1 tablet, tablet
Ingredients
Upadacitinib hemihydrate, ID: 789397000 — 45 mg based on base substance
Form & Route
tabletmodified-release.oral
Modified-release tablet, Oral
Controlled drug
No Controlled Drug Status

Products

Rinvoq 45mg modified-release tablets (AbbVie Ltd)

Rinvoq 45mg modified-release tablets

SNOMED code
41085811000001102
Supplier
AbbVie Ltd
Licensed as
Medicines - MHRA/EMA
Availability restrictions
None
Licensed route
Oral
Pack name & codeStatusGTIN, EAN barcodesPricePrescribingReimbursementPack
Rinvoq 45mg modified-release tablets (AbbVie Ltd) 28 tablet 4 x 7 tablets
41085911000001107   ref. pack		💯 Available

Legal category: POM		08054083024004
NHS Indicative Price
£2,087		• Hospital
  • • Prescription Charges
  • • Dispensing Fees
  • • Broken Bulk
  • • Calendar Pack
  • • Discount not deducted - automatic
 —

Reference packs

Upadacitinib 45mg modified-release tablets 28 tablet
SNOMED code
41085611000001101
Quantity and unit
28 tablet
Packs